NEW YORK--(BUSINESS WIRE)--NeoStem, Inc. (OTCBB:NEOI), the first company to specialize in the collection, processing and storage of stem cells from healthy adult donors for personal use in times of critical medical need, has announced that Richard Gatti, M.D., a professor at the University of California, Los Angeles (UCLA) and renowned Pathologist at the UCLA Medical Center, has joined the Company’s Advisory Board. Dr. Gatti was one of the early pioneers of bone marrow transplantation, among the earliest known forms of adult stem cell therapeutics, for immunodeficiency in the late sixties.
